Financial Statements · Financial Reporting
PharmaSynth AS
Official identifier 11044101Record date 31 Dec 2025
EstoniaReport
- Legal formThe legal or organisational form recorded by the Estonian Business Register. Learn more
- AS
- Report status
- Registered
Dates
- Reporting year
- 2025
- Period start
- 1 Jan 2025
- Submitted date
- 29 Jun 2026
Report
- Consolidated
- No
- Audited
- Yes
Financial metrics
| Statement | Metric | Value |
|---|---|---|
| Balance sheet | Assets | 1,368,917 |
| Balance sheet | Cash and cash equivalents | 678,862 |
| Balance sheet | Current assets | 1,183,550 |
| Balance sheet | Current liabilities | 84,409 |
| Balance sheet | Equity | 1,284,508 |
| Balance sheet | Share capital at nominal value | 57,180 |
| Balance sheet | Non-current assets | 185,367 |
| Balance sheet | Retained earnings (loss) from previous periods | 985,121 |
| Income statement scheme 1 | Depreciation and impairment of non-current assets | -41,703 |
| Income statement scheme 1 | Labour costs | -422,547 |
| Income statement scheme 1 | Revenue | 896,270 |
| Income statement scheme 1 | Annual period profit / loss | 236,116 |
| Income statement scheme 1 | Operating profit (loss) | 289,216 |
| Income statement scheme 1 | Profit (loss) before income tax | 236,116 |
| Profit distribution proposal | Retained earnings (loss) from previous periods | 985,121 |
| Note: Labour costs | Employees | 9 |
| Note: Labour costs | Labour costs | 422,547 |
Linked company
Company: PharmaSynth AS